Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Olmutinib (INN) is an investigational anti-cancer drug. It acts by covalently bonding to a cysteine residue near the kinase domain of epidermal growth factor receptor (EGFR).
Overview, Related Topics & Entities
Explore the main themes, entities and connections around Olmutinib. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug egfr 2015 hanmi epidermal cancer 2016 mutation south korea approved 30 inn t790m investigational anti-cancer acts covalently bonding cysteine
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Olmutinib | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Olmutinib | ATC code | L01EB06 (WHO) | 1.00 | infobox |
| Olmutinib | CAS Number | 1353550-13-6 | 1.00 | infobox |
| Olmutinib | ChemSpider | 45743494 | 1.00 | infobox |
| Olmutinib | CompTox Dashboard (EPA) | DTXSID001319119 | 1.00 | infobox |
| Olmutinib | Formula | C26H26N6O2S | 1.00 | infobox |
| Olmutinib | KEGG | D10859 | 1.00 | infobox |
| Olmutinib | Legal status | Approved in South Korea | 1.00 | infobox |
| Olmutinib | Molar mass | 486.59 g·mol−1 | 1.00 | infobox |
| Olmutinib | Other names | HM-61713, BI-1482694 | 1.00 | infobox |
| Olmutinib | PubChem CID | 54758501 | 1.00 | infobox |
| Olmutinib | Routes of administration | By mouth | 1.00 | infobox |
| Olmutinib | UNII | CHL9B67L95 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.